In patients with ST-segment elevation myocardial infarction (STEMI) with multivessel coronary artery disease, the time at which complete revascularization of nonculprit lesions should be performed ...

The benefit of complete revascularization in older patients (≥75 years of age) with myocardial infarction and multivessel disease remains unclear. In this multicenter, randomized trial, we assigned ...

Immediate multivessel percutaneous coronary intervention (PCI) is non-inferior to staged multivessel PCI for reducing death and ischaemic events in patients with ST-segment elevation myocardial ...

A new study from Denmark conducted over a 16-year period shows a 30% reduction in the 1-year mortality rate following percutaneous coronary intervention (PCI) for ST-segment elevation myocardial ...

MADRID, Spain—Routine use of CT angiography after PCI for left main coronary artery disease does not lower the risk of major adverse cardiac events, results of the PULSE trial show. There was a signal ...

Please provide your email address to receive an email when new articles are posted on . Among patients with diabetes, those taking a GLP-1 had better 3-year survival rates after PCI for a heart attack ...

The advent of thrombolytic therapy initiated the era of pharmacologic reperfusion in the acute phase of myocardial infarction (MI). Although it was a major improvement in the treatment of acute MI ...